07/18/2017 - 2:14pm

The combined products have a market size of $315.9 million for the 12 months ended May 2017 according to QuintilesIMS data.

07/18/2017 - 12:15pm
The organization has named Kristin Murphy its director of federal affairs, promoting Michael Brzica to the role of VP federal government affairs.
 
07/17/2017 - 2:59pm

The drug had annual U.S. sales of $88 million for the 12 months ended May 2017, according to QuintilesIMS data.

07/17/2017 - 2:34pm

The drug had U.S. sales of approximately $1.8 billion for the 12 months ended May 2017, according to QuintilesIMS data.

07/17/2017 - 11:48am

Jean Coutu founder Jean Coutu spoke out regarding negotiations with Quebec around dispensing fees, according to a report published last week by Canada's Bell Media. Jean Coutu earlier this year agreed to surrender $300 million in collected dispensing fees in return for smaller manufacturer rebates that cut into pharmacy operating margins. "It is an average of $100,000 for each of our locations," Coutu told shareholders BellMedia reported. "It was extremely difficult to digest." (Bell Media)

07/14/2017 - 11:23am

Mike Hotra joins the organization as VP of its public affairs team, and Ken McKay is the advocacy organization’s new VP state government affairs. 

07/11/2017 - 12:53pm
The company now offers 25- and 35-mg dosage strengths of its generic of Focalin XR extended-release tablets. 
07/11/2017 - 12:45pm

Rachel Sher was most recently a senior policy analyst in the Food and Drug Administration’s Office of Policy.

 
07/06/2017 - 3:19pm

The approval adds to the 5-, 10-, 15-, 20- and 30-mg capsules the company has previously launched of the generic.